Beyond the first dose: Systematic review on external beam radiotherapy for locoregional breast cancer recurrence (2026) Nano J, Shen Y, Allwohn L, Behzadi ST, Kiesl S, Maier S, Moser R, et al. Journal article, Review article Standardized patient coaching improves therapy persistence in patients with hormone receptor–positive, HER2–negative advanced/metastatic breast cancer treated with abemaciclib (2026) Welslau M, Fasching P, Semmler-Lins N, Mueller L, Belleville E, Rieger L, Uhrig S, et al. Journal article Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer (2026) Billaud A, Figlioli G, Mooser C, Casamassima I, Azzoni V, Srivatsa J, Colombo M, et al. Journal article Artificial intelligence as treatment support in breast cancer: current perspectives (2025) Lukac S, Putz F, De Micheli G, Corti C, Janni W, Tolaney SM, Curigliano G, et al. Journal article, Review article Partial breast irradiation after sentinel lymph node biopsy omission: Is it a valid alternative to whole breast Irradiation? Analysis of the dose to the sentinel lymph node region during whole breast irradiation vs. partial breast irradiation (2025) Behzadi ST, Moser R, Düsberg M, Aigner M, Nano J, Kiesl S, Lammert J, et al. Journal article Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer (2025) O'Shaughnessy J, Tolaney SM, Yardley DA, Hart L, Razavi P, Fasching P, Janni W, et al. Journal article Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk (2025) Müller V, Hörner M, Thill M, Banys-Paluchowski M, Schmatloch S, Fasching P, Harbeck N, et al. Journal article Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer (2025) Walter CB, Hartkopf AD, Hein A, Fasching P, Kolberg HC, Hadji P, Tesch H, et al. Journal article Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials (2022) Pfaffendorf C, Vonthein R, Krockenberger-Ziegler K, Dellas K, Schreiber A, Uhlemann D, Dinges S, et al. Journal article Mammographic density and prognosis in primary breast cancer patients (2021) Heindl F, Fasching P, Hein A, Hack C, Heusinger K, Gaß P, Pöschke P, et al. Journal article